It is clear that regulatory changes are transforming the OTC derivatives space, from execution to settlement. There are many challenges at play here. As we head into 2012, market participants will need to manage large volumes of data in order to clear and process trades, and we will see new pressures on the cost and the more effective use of capital. In response to this industry transformation, my team and I have identified 10 key trends shaping OTC derivatives today.
I have posted the full list below. How is your firm approaching these 10 trends in OTC derivatives?
We recently recorded several podcasts with industry analysts to discuss current trends and challenges facing the capital markets. One was with Kevin McPartland, principal and director of fixed income research at TABB Group, who spoke about regulatory reform and its impact on capital markets. SunGard’s own Brenda Mickiewicz, senior manager of analyst relations, sat down [...]
Author: Peter Banham, global head of strategy, SunGard’s capital markets business
The words we use to define and think about these complex issues can not only help us make sense of the regulatory changes but also complicate or confuse…
